| pubmed-article:10966553 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0040207 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C1948041 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C1979963 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0919737 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C2003903 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C0521115 | lld:lifeskim |
| pubmed-article:10966553 | lifeskim:mentions | umls-concept:C2348480 | lld:lifeskim |
| pubmed-article:10966553 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10966553 | pubmed:dateCreated | 2000-9-27 | lld:pubmed |
| pubmed-article:10966553 | pubmed:abstractText | We examined the ex vivo platelet aggregation profiles of patients who underwent percutaneous coronary intervention and received either abciximab, ticlopidine, or both agents. | lld:pubmed |
| pubmed-article:10966553 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10966553 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10966553 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10966553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10966553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10966553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10966553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10966553 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10966553 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10966553 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10966553 | pubmed:issn | 0002-8703 | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:JordanR ERE | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:TaylorR JRJ | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:EffronM BMB | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:KleimanN SNS | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:MascelliM AMA | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:FrederickBB | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:LanceE TET | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:MareshKK | lld:pubmed |
| pubmed-article:10966553 | pubmed:author | pubmed-author:GrazeiadeiNN | lld:pubmed |
| pubmed-article:10966553 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10966553 | pubmed:volume | 140 | lld:pubmed |
| pubmed-article:10966553 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10966553 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10966553 | pubmed:pagination | 492-501 | lld:pubmed |
| pubmed-article:10966553 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:meshHeading | pubmed-meshheading:10966553... | lld:pubmed |
| pubmed-article:10966553 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10966553 | pubmed:articleTitle | Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventions. | lld:pubmed |
| pubmed-article:10966553 | pubmed:affiliation | Baylor College of Medicine and the Methodist Hospital, Houston, TX, USA. | lld:pubmed |
| pubmed-article:10966553 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10966553 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10966553 | lld:pubmed |
